CHF

Timeline, a Swiss Longevity Biotech, Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders, including L’Oréal and Nestlé

Retrieved on: 
Wednesday, January 17, 2024

This marks a significant milestone for the company and includes strategic investments from two global industry leaders—L’Oréal and Nestlé.

Key Points: 
  • This marks a significant milestone for the company and includes strategic investments from two global industry leaders—L’Oréal and Nestlé.
  • "This strategic collaboration reflects the breakthrough multidimensional approach that we've always believed is necessary to make meaningful advancements for longevity and healthspan."
  • said Patrick Aebischer, Co-Founder and Chairman of Timeline “I want to thank L’Oréal, Nestlé and our longstanding investors for their commitment to longevity solutions rooted in the highest level of science”.
  • “Longevity is a new definition of beauty, at the intersection of different scientific disciplines, from decoding biological markers to analyzing external exposure.

HCL Group and UpLink Announce Winners of Zero Water Waste Challenge, Part of the Aquapreneur Innovation Initiative

Retrieved on: 
Wednesday, January 17, 2024

HCL Group committed $15 million investment in total to drive freshwater sector innovation for five years until 2027.

Key Points: 
  • HCL Group committed $15 million investment in total to drive freshwater sector innovation for five years until 2027.
  • In less than a year, HCL Group’s commitment saw a 10x return on its investment as the first cohort of ‘Aquapreneurs’ collectively raised $54.5 million after joining the UpLink Innovation Ecosystem.
  • View the full release here: https://www.businesswire.com/news/home/20240117146995/en/
    L- Roshni Nadar Malhotra, Chairperson, HCLTech along with the two Aquapreneurs at World Economic Forum 2024 (Photo: Business Wire)
    The Zero Water Waste Challenge is the second out of five innovation challenges, under HCL Group and UpLink’s Aquapreneur Innovation Initiative.
  • The focus of this year’s challenge aimed at capturing and protecting freshwater supply, water reuse and recycling of materials and saving water in agriculture.

Hamilton Reserve Bank Accepts 70 Deposit Currencies, Expanding Staff, Offices Worldwide In 2024

Retrieved on: 
Wednesday, January 17, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240117015042/en/
    Hamilton Reserve Bank is now accepting 70 different currencies as client deposits, including all of the world’s major currencies.
  • Powered by Temenos , the world’s largest banking software provider, Hamilton Reserve Bank enables fast customer onboarding 100% online in 20 minutes .
  • Ghassan Nasr, CEO , International Markets of Hamilton Reserve Bank commented: “What makes Hamilton Reserve Bank so successful as the primary local bank for our worldwide clients is quite simple: total privacy, fast banking transactions, and best hassle-free private banking services.
  • These 70+ deposit currencies have well-positioned Hamilton Reserve Bank as the ‘local global bank’ for many clients.

Holcim intends to list its North American business in the US

Retrieved on: 
Sunday, January 28, 2024

The newly-listed business will be committed to driving long-term growth in the rapidly expanding North American market and unlocking value for all its stakeholders.

Key Points: 
  • The newly-listed business will be committed to driving long-term growth in the rapidly expanding North American market and unlocking value for all its stakeholders.
  • The Board has tasked Jan Jenisch to lead the planned US listing of Holcim's North America business.
  • The success of our North American business makes it the leading pure-play building solutions company in the region.
  • Holcim is preparing a full capital market separation and US listing of its North American business.

Holcim intends to list its North American business in the US

Retrieved on: 
Sunday, January 28, 2024

The newly-listed business will be committed to driving long-term growth in the rapidly expanding North American market and unlocking value for all its stakeholders.

Key Points: 
  • The newly-listed business will be committed to driving long-term growth in the rapidly expanding North American market and unlocking value for all its stakeholders.
  • The Board has tasked Jan Jenisch to lead the planned US listing of Holcim's North America business.
  • The success of our North American business makes it the leading pure-play building solutions company in the region.
  • Holcim is preparing a full capital market separation and US listing of its North American business.

DKSH Acquires Healthcare Distributor Medipharm in Brunei

Retrieved on: 
Wednesday, January 17, 2024

DKSH has signed an agreement to acquire Medipharm Sdn Bhd (“Medipharm”), one of the leading pharmaceutical and medical devices distributors in Brunei.

Key Points: 
  • DKSH has signed an agreement to acquire Medipharm Sdn Bhd (“Medipharm”), one of the leading pharmaceutical and medical devices distributors in Brunei.
  • With this acquisition, DKSH Healthcare grows its business in line with the strategy to expand its footprint in the Asia-Pacific region.
  • Zurich, Switzerland, January 15, 2024 – DKSH has announced today that it signed an agreement to acquire Medipharm, one of the leading pharmaceutical and medical devices distributors in Brunei.
  • DKSH and Medipharm build on a longstanding strategic partnership, with Medipharm having operated as DKSH’s sub distributor in Brunei for the last 25 years.

DocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer base

Retrieved on: 
Wednesday, January 17, 2024

Inflection point confirmed and basis for sustainable, profitable growth strengthened

Key Points: 
  • Inflection point confirmed and basis for sustainable, profitable growth strengthened
    DocMorris has clearly achieved its revenue target for the full year 2023.
  • In the main market of Germany, external revenue in the fourth quarter rose by 14.7 per cent in local currency compared to the previous year.
  • OTC revenue grew by 18.4 per cent in local currency in the fourth quarter, while Rx revenue declined only slightly by 2.2 per cent in local currency.
  • At the end of 2023, the number of active customers [2] increased by 300,000 to 9.1 million compared to the previous quarter.

Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund

Retrieved on: 
Wednesday, January 17, 2024

Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund

Key Points: 
  • Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund
    Media release of January 15, 2024
    Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund
    Generative Artificial Intelligence (GenAI) is bringing about an unprecedented technological transformation.
  • “The investment approach we are taking with the Bellevue AI Health (Lux) Fund that was launched on November 30, 2023 is different.
  • Healthcare will benefit greatly from GenAI,” says Co-Portfolio Manager Stefan Blum, which explains the rationale behind the launch of Bellevue Asset Management's latest healthcare fund.
  • The IT-related risks of implementing AI in healthcare are more calculable than in other industries because healthcare is such a highly regulated market.

Basilea announces acquisition of preclinical antibiotics program from Spexis

Retrieved on: 
Monday, January 15, 2024

We are excited by the addition of this new program to our growing pipeline and to continue the development of this targeted antibiotics class, which has the potential to address an unmet medical need in the treatment of severe bacterial infections in the hospital.”

Key Points: 
  • We are excited by the addition of this new program to our growing pipeline and to continue the development of this targeted antibiotics class, which has the potential to address an unmet medical need in the treatment of severe bacterial infections in the hospital.”
    The antibiotics were developed within Spexis’ Outer Membrane Protein Targeting Antibiotics (OMPTA) program and selectively disrupt the lipopolysaccharide transport bridge, an essential structure in Gram-negative bacteria.
  • This results in a loss of the integrity of the outer cell membrane, intracellular accumulation of lipopolysaccharides and killing of the bacteria.
  • The program was funded in part by CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator).2 This underscores the potential of this novel class of antibiotics.
  • In addition, Basilea assumes the rights and obligations of Spexis, including potential low single-digit percentage royalties on sales, under licensing agreements.

StickIt Technologies Engages CHF Capital Markets and ITG Independent Trading Group

Retrieved on: 
Tuesday, January 16, 2024

TEL AVIV, Israel, Jan. 16, 2024 /PRNewswire/ -- StickIt Technologies Inc. (the "Company" or "StickIt") (CSE: STKT), the parent company of StickIt Technologies Inc., an Israeli technology and cannabinoid company, is pleased to announce that it has retained CHF Capital Markets Inc. ("CHF") and an Independent Trading Group ("ITG") effective immediately.

Key Points: 
  • TEL AVIV, Israel, Jan. 16, 2024 /PRNewswire/ -- StickIt Technologies Inc. (the "Company" or "StickIt") (CSE: STKT), the parent company of StickIt Technologies Inc., an Israeli technology and cannabinoid company, is pleased to announce that it has retained CHF Capital Markets Inc. ("CHF") and an Independent Trading Group ("ITG") effective immediately.
  • No performance factors are contained in the agreement, and ITG will not receive shares or options as compensation.
  • "Engaging CHF Capital Markets and ITG is an important step in our journey to bring our unique, patented cannabinoid technology to the forefront of Canadian investors' minds.
  • Working together with ITG, experts in market-making, allows management to focus on building the business," said Eli Ben-Haroosh, CEO and Director.